Table 3.
Pituitary function before and after transsphenoidal surgery.
MAL (n=19) | CYS (n=62) | BEN (n=25) | INF (n=10) | |||||
---|---|---|---|---|---|---|---|---|
Cases of pituitary disturbances | Preexisting | Persistent | Preexisting | Persistent | Preexisting | Persistent | Preexisting | Persistent |
Hypothyroidism | 2 | 2 | 6 | 4 | 2 | 2 | 3 | 3 |
Hyperprolactinemia | 2 | 0 | 16 | 4 | 2 | 0 | 2 | 1 |
Hypogonadism | 4 | 4 | 6 | 4 | 2 | 2 | 3 | 2 |
Hypocortisolism | 2 | 2 | 7 | 6 | 2 | 2 | 3 | 3 |
Total | 10 | 8 | 35 | 18 | 8 | 6 | 11 | 9 |
No. of new cases after TSS (%) | ||||||||
Hypothyroidism | 0 | 0 | 0 | 0 | ||||
Hyperprolactinemia | 0 | 0 | 0 | 0 | ||||
Hypogonadism | 1 | 1 | 2 | 0 | ||||
Hypocortisolism | 1 | 2 | 2 | 0 | ||||
Permanent DI | 2 | 1 | 0 | 0 | ||||
Total of new cases | 4 | 4 | 4 | 0 | ||||
Follow-up (months) | 46±33 | 35±30 | 67±38^‡ | 25±9 |
Follow-up is expressed as mean ± SD; DI: diabetes insipidus. Data regarding pre-operative hormone replacement were available for every patient.
Impairment of more than one axis was observed in a given patient was as follows:
- group MAL (two pts. with two axes altered; one pt. with four axes altered)
- group CYS (five pts. with two axes altered; three pts. with three axes altered)
- group BEN (two pts. with two axes altered; one pt. with three axes altered)
- group INF (one pts. with two axes altered; one pt. with three and one pt. with four axes altered)
p<0.05 vs. group INF
p<0.01 vs. group CYS